APSR2026-294

Yes
Late-Breaking
Submitted
Oral Presentation
AO14-001
 
 
https://storage.unitedwebnetwork.com/files/1285/1217062-46903-Abstract ID-AO14-001_434863.pptx
Format: PPTX Only
 
Format: PDF Only
06. Tuberculosis
3

No more than 15 authors can be listed.
Please ensure the authors are listed in the right order.
If there are multiple affiliations, please use the "+" button next to "Select Country/Region" to add additional affiliation fields.

Tungalagtuya Dashtseren * Mongolian National University of Medical Sciences Tuberculosis dispensary Ulaanbaatar Mongolia
Binderya Erdeneochir - Bayanzurkh District Health Center Tuberculosis dispensary Ulaanbaatar Mongolia
Dorjderem Radnaa - National Center for Communicable Disease Tuberculosis Surveillance and Research Department, Ulaanbaatar Mongolia
 
 
 
 
 
 
 
 
 
 
 
 
Presenting Author Details
Tungalagtuya
Dashtseren
orkhontungaa@gmail.com
+97688081792
31-40
Mongolia
Original Research
Assessing the side effects of multidrug-resistant tuberculosis treatment
Maximum 25 words
Abstract Content
In Mongolia, 3002 cases of tuberculosis were registered in 2024, of which 91% (n=2232) were drug-susceptible tuberculosis and 9% (n=268) were drug-resistant tuberculosis. The drugs used to treat tuberculosis cause a variety of side effects, including nausea, vomiting, loss of appetite, diarrhea, yellowing of the skin and mucous membranes, anemia, blue-spotted rash on the skin, chest pain, palpitations, abdominal pain, joint pain, and dizziness, depending on the biological characteristics of the patient and other factors.
162 patients who received treatment for drug-resistant tuberculosis at the TB dispensary of the Health Center of Bayanzurkh District from 2019 to 2024 were included. Statistical analysis were performed using MS Excel and Stata 17.0.
Of all participants, 64% were male, mean age was 39.08±1.40 years, 59% had a secondary education, 38% were unemployed, and 69% lived in ger districts. Side effects of the drug were detected in 76% of the patients. Side effects such as nausea (77%), vomiting (56%), joint pain (52%), itching and rash (49%), and palpitations (36%) were detected. Side effects of the drug were observed in 62% of the patients treated with the short-term 9-month regimen (p=0.01), 28% of the patients treated with the BpaL and BpaLM regimens (p=0.04), and 14% of the patients changed their treatment regimens.
Although a variety of side effects were observed during treatment, they were not fully managed clinically, and 67% of patients paid for their treatment themselves, while 12% were covered by health insurance. There is an urgent need to improve the management of drug therapy against the side effects of multidrug-resistant tuberculosis treatment at the policy level.
 
 
 
 
 
Yes
No
 
JPG or JPEG or PNG format ONLY
multidrug-resistant tuberculosis, drug side effects
maximum 3 keywords and no abbreviations, separated by commas
 
273